Temsirolimus

CAS : 162635-04-3

Ref. TM-T2145

Informations sur le produit

• Nom: Temsirolimus
• Synonymes: NSC 683864, CCI-779, (1R,2R,5S)-5-{(2S)-2-[(3S,6R,7E,9R,10R,12R,14S,15Z,17E,19E,21S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate, 4-{2-[(7E,15Z,17E,19E)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate, 40-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin, Cci 779, Ccl-779, NSC 683864, Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate, Temsorolimus, Torisel, Way-Cci 779
• CAS: 162635-04-3

Description

Temsirolimus (CCI-779) is a specific mTOR inhibitor ( IC50: 1.76 μM), used in the treatment of advanced renal cell cancer.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 1030.29
• Formule: C₅₆H₈₇NO₁₆
• Degré de pureté: 100%
• Couleur/Forme: White Crystalline Powder